NPI: 1316992134 · NAPLES, FL 34119 · General Acute Care Hospital · NPI assigned 05/23/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR) |
| NPI Enumeration Date | 05/23/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,769 | $173K |
| 2019 | 27,457 | $313K |
| 2020 | 23,612 | $242K |
| 2021 | 37,610 | $499K |
| 2022 | 38,980 | $732K |
| 2023 | 13,212 | $246K |
| 2024 | 564 | $15K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 6,197 | 5,134 | $341K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 5,681 | 4,913 | $314K |
| 36415 | Collection of venous blood by venipuncture | 14,016 | 9,258 | $298K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 996 | 871 | $168K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,540 | 2,886 | $154K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3,386 | 2,574 | $143K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,259 | 1,067 | $131K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,160 | 1,762 | $129K |
| G0378 | Hospital observation service, per hour | 1,141 | 911 | $117K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2,033 | 1,753 | $64K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 811 | 716 | $48K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,162 | 267 | $27K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,141 | 963 | $18K |
| 99218 | 145 | 133 | $14K | |
| 80053 | Comprehensive metabolic panel | 10,384 | 7,992 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10,979 | 8,345 | $11K |
| 81025 | 2,175 | 1,938 | $11K | |
| 71045 | Radiologic examination, chest; single view | 4,454 | 3,709 | $9K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,001 | 2,059 | $9K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,815 | 1,534 | $9K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,939 | 1,616 | $8K |
| 87400 | 412 | 372 | $8K | |
| 82962 | 2,945 | 1,057 | $8K | |
| 94760 | 3,474 | 1,567 | $8K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,195 | 3,950 | $8K |
| 85610 | 3,764 | 2,970 | $8K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 225 | 183 | $7K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,413 | 3,588 | $7K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 249 | 217 | $7K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 43 | 37 | $6K |
| 84484 | 5,066 | 2,973 | $6K | |
| 83735 | 3,590 | 2,458 | $6K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 40 | 37 | $6K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 879 | 717 | $6K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,865 | 2,286 | $6K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,934 | 1,649 | $6K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 404 | 338 | $5K |
| 85027 | 2,440 | 1,668 | $5K | |
| J2704 | Injection, propofol, 10 mg | 1,440 | 1,161 | $4K |
| 81001 | 3,092 | 2,599 | $4K | |
| 81003 | 2,059 | 1,768 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | 418 | 361 | $4K |
| 83690 | 3,165 | 2,654 | $4K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 634 | 526 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,825 | 1,470 | $3K |
| 87428 | 1,339 | 1,166 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 485 | 404 | $3K |
| 85730 | 2,698 | 2,181 | $3K | |
| 80061 | Lipid panel | 1,665 | 1,366 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,701 | 2,066 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 429 | 369 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 222 | 187 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 198 | 115 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | 400 | 286 | $2K |
| 96376 | 504 | 299 | $2K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 253 | 224 | $1K |
| 97161 | 60 | 55 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,354 | 899 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,880 | 1,235 | $1K |
| 87430 | 117 | 111 | $1K | |
| 86850 | 89 | 80 | $1K | |
| 83880 | 1,484 | 1,192 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 272 | 238 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,628 | 1,324 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,101 | 904 | $879.21 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 23 | 12 | $855.35 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 23 | 12 | $855.35 |
| 84439 | 106 | 82 | $789.89 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 23 | 21 | $698.97 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 175 | 37 | $620.19 |
| 82550 | 427 | 332 | $600.30 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,393 | 1,060 | $577.99 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 12 | 12 | $432.69 |
| G1002 | Clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria program | 332 | 233 | $350.46 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 664 | 577 | $225.67 |
| 85379 | 353 | 304 | $137.67 | |
| 88342 | 37 | 36 | $105.53 | |
| 82248 | 87 | 81 | $89.72 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 268 | 251 | $88.13 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 14 | 14 | $72.41 |
| 87040 | 228 | 115 | $70.14 | |
| 83605 | 455 | 356 | $53.72 | |
| 94664 | 63 | 41 | $51.72 | |
| 87186 | 168 | 149 | $30.48 | |
| 87077 | 171 | 152 | $29.58 | |
| 86900 | 134 | 118 | $17.02 | |
| 86901 | 134 | 118 | $17.02 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 146 | 106 | $9.72 |
| 86140 | 141 | 122 | $6.33 | |
| 82043 | 25 | 24 | $3.09 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 392 | 202 | $0.00 |
| 84100 | 117 | 87 | $0.00 | |
| 80179 | 16 | 13 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 80 | 64 | $0.00 |
| 84702 | 29 | 24 | $0.00 | |
| 80143 | 17 | 14 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 13 | 13 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 13 | 12 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 616 | 475 | $0.00 |
| 82077 | 258 | 219 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 77 | 55 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 12 | 12 | $0.00 |
| 80069 | 12 | 12 | $0.00 | |
| C1769 | Guide wire | 15 | 13 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 26 | 18 | $0.00 |
| 82607 | 18 | 13 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 13 | 13 | $0.00 |
| 84703 | 13 | 12 | $0.00 |